Risk of Development of the Metabolic Syndrome After Orthotopic Liver Transplantation

Transplantation Proceedings

Volumn 42, Issue 2, 2010, Pages 663-665

  Ruiz Rebollo, M L ^a   Sanchez Antolin G ^a   Garcia Pajares F ^a   Fernandez Orcajo P ^a   Gonzalez Sagrado M ^a   Citores Pascual M A ^a   Velicia Llames, R ^a   Caro Paton A ^a  

^a Department of Gastroenterology and Hepatology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CORTICOSTEROID; CYCLOSPORIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TRIACYLGLYCEROL;

ADULT; ALCOHOL LIVER CIRRHOSIS; ANAMNESIS; ARTERIAL PRESSURE; ARTICLE; BODY MASS; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FOLLOW UP; GENDER; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; FEMALE; GRAFT REJECTION; HUMANS; LIVER TRANSPLANTATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS;

EID: 77949465569     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.02.018     Document Type: Article

References (9)

1. Shener P.A., Magliocca J.F., Bodian C.A., et al. Long-term medical complications in patients surviving 5 years after liver transplant. Transplantation 69 (2000) 781
2. Muñoz S., Elgenaidi H., et al. Cardiovascular risk factors after liver transplantation. Liver Transpl 11 (2005) S52
3. Bianchi G., Marchesini G., Marzocchi R., et al. Metabolic syndrome in liver transplantation: relation to etiology and nosuppression. Liver Transpl 14 (2008) 1648
4. Richards J., Gunson J., and Neuberger J. Weight gain and obesity after liver transplantation. Trasplant Int 18 (2005) 461
5. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults/Adult Treatment Panel III. JAMA 285 (2001) 2486
6. Laryea M., Watt K.D., Molinari M., et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl 13 (2007) 1109
7. Stegall M.D., Everson G., Schroter G., et al. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension and obesity. Transplantation 60 (1995) 1057
8. Alegria E., Cordero A., Laclaustra M., et al. Prevalence of metabolic syndrome in the Spanish working population: MESYAS registry. Rev Esp Cardiol 58 (2005) 797
9. Khalili M., Lim J.W., Bass N., et al. New onset diabetes mellitus after liver transplantation. The critical role of hepatitis C Infection. Liver Transpl 8 (2002) 708